Alimera Sciences Inc logo

Alimera Sciences Inc (ALIM)

Delisted
18 Sep 2024
NASDAQ (NMS) NASDAQ (NMS)
$
5. 54
0
0%
$
301.29M Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.67 Eps
$ 5.54
Previous Close
Investors:
Day Range
5.54 5.54
Year Range
2.61 5.65
Want to track ALIM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?

Alimera Sciences (ALIM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks | 2 years ago
Alimera Sciences (ALIM) Reports Q2 Loss, Tops Revenue Estimates

Alimera Sciences (ALIM) Reports Q2 Loss, Tops Revenue Estimates

Alimera Sciences (ALIM) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.44 per share a year ago.

Zacks | 2 years ago
SHAREHOLDER ALERT: Weiss Law Investigates Alimera Sciences, Inc.

SHAREHOLDER ALERT: Weiss Law Investigates Alimera Sciences, Inc.

NEW YORK, NY / ACCESSWIRE / June 26, 2024 / Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Alimera Sciences, Inc. ("Alimera" or the "Company") (NASDAQ:ALIM), in connection with its acquisition by ANI Pharmaceuticals, Inc. (NASDAQ: ANIP). Under the merger agreement, the Company's shareholders will receive $5.50per share in cash at closing and one non-tradable contingent value right ("CVR") to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027.

Accesswire | 2 years ago
Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals

Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals

Alimera (ALIM) is set to be acquired by ANI Pharmaceuticals for approximately $381 million in upfront consideration. The transaction is expected to close in the third quarter of 2024.

Zacks | 2 years ago
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?

Why Is Alimera Sciences (ALIM) Stock Up 77% Today?

Alimera Sciences (NASDAQ: ALIM ) stock is rocketing higher on Monday after the pharmaceutical company announced an acquisition deal with ANI Pharmaceuticals (NASDAQ: ANIP ). This agreement will have ANI Pharmaceuticals paying $5.50 per share for ALIM stock.

Investorplace | 2 years ago
Alimera Sciences stock rallies 75% on ANI Pharmaceuticals deal

Alimera Sciences stock rallies 75% on ANI Pharmaceuticals deal

Alimera Sciences Inc (NASDAQ: ALIM) rallied a whopping 75% in premarket today after ANI Pharmaceuticals Inc (NASDAQ: ANIP) said it will buy the Alpharetta, Georgia based company for about $381 million.  ANI shares are roughly flat at writing.

Invezz | 2 years ago